Cells have evolved elaborate mechanisms (checkpoints) to monitor genomic integrity in order to ensure the highfidelity transmission of genetic information. Cells harboring defects in checkpoint pathways respond to DNA damage improperly, which in turn may enhance the rate of cancer development. Ionizing radiation (IR) primarily leads to double-strand DNA breaks (DSBs), which activate DNA damage checkpoints to initiate signals ultimately leading to a binary decision between cell death and cell survival. TP53 has been recognized as an important checkpoint protein, functioning mainly through transcriptional control of target genes that influence multiple response pathways and leading to the diversity of responses to IR in mammalian cells. We review how the tumor suppressor P53 is involved in the complex response to IR to enforce the cell's fate to live by inducing the growth arrest coupled to DNA damage repair or to die by inducing irreversible growth arrest or apoptosis. Moreover, recent insights have emerged in our understanding of how P53 modulates radiosensitivity in tissues following IR as well as its role in sensitizing cells to chemo-and radiotherapy. The P53 pathway remains an attractive target for exploitation in the war on cancer.
Introduction
'DNA is, in fact, so precious and so fragile that we now know that the cell has evolved a whole variety of repair mechanisms to protect its DNA from assaults by radiation, chemicals and other hazards. This is exactly the sort of thing that the process of evolution by natural selection would lead us to expect ' (Sir Francis Crick (1988) What Mad Pursuit. Basic Books: New York). As Crick expected, life does not take these challenges without response. Cells have evolved elaborate defense mechanisms to protect against DNA damage (Hartwell and Weinert, 1989; Elledge, 1996; Kaufmann and Paules, 1996; Shackelford et al., 1999) . The first insight into this type of process was obtained in bacteria. In Escherichia coli, DNA damage or inhibition of DNA replication generates a signal that activates RecA protein to proteolyze the Lex A repressor (Walker, 1985) . This activated SOS response is associated with the induction of an entire group of genes that either participate in DNA repair or block cell division. What is important in this type of response is that cell cycle arrest caused by DNA damage is not caused by the damage per se, but by specific surveillance mechanisms that detect mistakes and induce negative regulators of cell cycle transitions. As this response is equivalent to the activation of a checkpoint (Hartwell and Weinert, 1989; Hartwell et al., 1994) , which means the positions of control that ensure the order of events in the cell cycle, it becomes apparent that the concept of checkpoint retains validity from bacteria to mammals. DNA damage checkpoint has been understood as ensuring the cascade of responses to DNA damage, ultimately leading to the outcome of cell survival or cell death (Clarke et al., 1993; Lowe et al., 1993; Elledge, 1996; Paulovich et al., 1997; Zhou and Elledge, 2000) , instead of the original understanding of the ability of cells to arrest the cell cycle in response to DNA damage, allowing cells to have time to repair damaged DNA (Zhou and Elledge, 2000) .
One of the key proteins in checkpoint pathways is the tumor suppressor P53, which coordinates DNA repair with cell cycle progression and apoptosis. P53 has been considered as the guardian of genome (Lane, 1992; Gottlieb and Oren, 1996; Ko and Prives, 1996; Levine, 1997; Prives and Hall, 1999; Morris, 2002; Tlsty, 2002) , which maintains genomic stability. More than 50% of tumors have a P53 gene mutation (Hollstein et al., 1991) . P53 knockout mice show a high incidence of tumor development (Donehower, 1996) , and germ line mutation of one P53 allele in humans gives rise to the Li-Fraumeni cancer-susceptibility syndrome (Donehower, 1996) . Its pivotal roles in checkpoint control result from its unique biochemical features. It is a nuclear phosphoprotein containing at least three domains: an N-terminal acidic transactivating domain; a central evolutionary conserved DNA-binding domain; and a complex C-terminal domain that houses nuclear localization sequences, a homotetramerization domain and a putative DNA damage recognition domain. The majority of mutations found in human tumors are missense mutations clustered into the central DNAbinding domain (Friend, 1994; Greenblatt et al., 1994) . Wild-type (WT) P53 protein has the capacity to both activate and repress gene transcription in order to exert its function in response to genotoxic stress. It is a shortlived protein and will be stabilized and activated upon a wide range of cellular stresses (Prives and Hall, 1999; Appella and Anderson, 2000) . The biochemical function of P53 that best explains its effects is its sequencespecific transcriptional activity, which transactivates target genes through binding a consensus motif in their genomic DNA sequences (Bourdon et al., 1997; ElDeiry, 1998; El-Deiry et al., 1992; Funk et al., 1992) . The roles of P53 as a tumor suppressor are predominantly, if not exclusively, mediated through its targets. WT P53 accumulation appears not to be mediated at the transcriptional level, but rather the WT P53 protein becomes stabilized following DNA damage (El-Deiry et al., 1992; Funk et al., 1992; Kastan et al., 1991a, b) . Abundance and activity of the tumor suppressor P53 are regulated by many different post-translational modifications. These include phosphorylation, acetylation, ribosylation, O-glycosylation, ubiquitination and SUMOylation (Melchior and Hengst, 2002) . So far, several important P53 regulators have emerged, including MDM2, a ring-finger ubiquitin ligase that is both a P53 target gene and a determinant of P53 stability; ARF, an inhibitor of MDM2, which increases the stability of P53; ATM, ATR and CHK1/CHK2, which can promote P53 stability by phosphorylating the sites on the P53 protein that interfere with the binding to MDM2; and P300 and PCAF histone acetyl transferases, which act as coactivators to promote P53 transcriptional activity (Gu et al., 1997; Espinosa and Emerson, 2001) .
The turning on and off of genes and the starting and stopping of processes such as cell growth, DNA damage repair and apoptosis are the overt consequences of many events in the dynamic state of the checkpoint control system. The role of P53 coupled into the system triggered by ionizing radiation (IR) will be discussed.
General cascade of IR responses
IR induces a large variety of DNA lesions, including single-and double-strand breaks (DSBs), and base and sugar damage (Hutchinson, 1985; Ward, 1988) ; among them, DSB is the most dangerous. Although cells can adapt to low levels of irreparable damage (Lee et al., 1998) , one DNA DSB can be sufficient to kill a cell if it is located in an essential gene or in metazoan, or it triggers apoptosis (Rich et al., 2000) . Therefore, the DSBs are generally considered as the typical form of DNA damage resulting from IR. In response to DNA damage, checkpoints ensure the signal transduction cascade, which consists of sensors, transducers and effectors (Zhou and Elledge, 2000) . Sensor proteins recognize the damage and probably act on DNA damage directly through a group of proteins including RAD9, RAD1, RAD17, HUS1 and others in fission yeast; their homologs RAD17, DDC1 RAD24, MEC3 and others in budding yeast; and RAD9, RAD1, RAD17, HUS1 and others in mammals, respectively (Michelson and Weinert, 1999; Zhou and Elledge, 2000) . The transducers are downstream signaling proteins that include kinases such as RAD3 in fission yeast, MEC1 in budding yeast, and ATM/ATR in mammals-all of which are capable of phosphorylating target proteins known as effector kinases, including CHK1/CHK2 in fission yeast, CHK1/RAD53 in budding yeast, and CHK1/CHK2 in mammals. The well-known effector responses to DNA damage are cell growth arrest, DNA damage repair and apoptosis (Khanna and Jackson, 2001) . The understanding of the network of interacting pathways that exert the checkpoint responses has benefited from yeast studies; however, in multicellular organisms, the response to DNA damage involving the P53 tumor suppressor protein appears much more complex (Wahl and Carr, 2001) . Figure 1 shows the model of the checkpoint pathways proposed based on recent studies in mammals in response to IR. Briefly, DSBs may be detected and bound by sensor proteins (RAD9, RAD1, RAD17, HUS1), and RAD17 may facilitate a RAD1-RAD9-HUS complex to recognize DNA damage. These mechanisms, together with BRCA1/53BP1, may help ATM to phosphorylate some target proteins (Edwards et al., 1999; Schultz et al., 2000; Zhou and Elledge, 2000; DiTullio et al., 2002; Wang et al., 2002) , including CHK1/CHK2, P53 and others. Bakkenist and Kastan (2003) Figure 1 General cascade of IR responses. Sensor proteins recognize DNA damage, bind to the damage and transduce the damage signal to the components in transducer phase, mainly ATM and its modifiers, followed by phosphorylation of target proteins. The outcome of this dynamic combination under certain circumstances is cell arrest coupled with DNA repair and cell survival or apoptotic cell death P53 and radiation responses P Fei and WS El-Deiry target proteins and other known and unknown proteins determine a cell's fate to live by inducing growth arrest, coupled with repair, or to die by inducing apoptosis. In this model, many steps need to be further clarified. 53BP1 acts upstream of ATM, but it was also found to be phosphorylated by ATM (Rappold et al., 2001; Fernandez-Capetillo et al., 2002) . Experiments to determine ATM activity in 53BP1À/À mice or 53BP1À/ 1À cell lines with a known genetic background would give clues as to the relation between ATM and 53BP1. H2AX is very important in the recruitment of NBS1, 53BP1 and BRCA1, but not RAD51, during the formation of irradiation-induced foci (based on a knockout mouse study) and is thus essential in facilitating the assembly of specific DNA-repair complexes on damaged DNA . It is phosphorylated in response to IR (Rogakou et al., 1998) and dependent on ATM . Thus, it is difficult to assign a proper position for H2AX in the above pathway. The early stages in the response to DNA damage are more obscure and await further study. It is possible that each player in checkpoint responses may possess multiple functions. This is true in some repair proteins (HMSH2, MLH1) that were found to have signaling roles besides the damage repair (Yan et al., 2001) . Individual proteins in checkpoint pathways may switch function from time to time, depending on the net outcome of dynamic combinations within a given cell.
Abundance and activation of WT P53 in IR responses
It has been 35 years since IR was shown to induce both a transient and prolonged G1 delay in human and rodent fibroblasts (Little, 1968) . A decade ago, it became understood that the cell growth delay involves elevated levels of WT P53 protein in mediating changes of cell cycle distribution in fibroblasts after IR (Kastan et al., 1991a, b; Dulic et al., 1994) . Subsequently, the importance of WT P53 protein in cell growth arrest mediated by IR was found in many systems such as human skin fibroblasts (DeSimone et al., 2000) , human lymphoma cells (Bae et al., 1995) and human melanoma lines (Bae et al., 1996) . The role of WT P53 was established in vivo in response to IR. P53 null-mice have been found to be resistant to apoptosis induced by gamma irradiation in the developing nervous system (Herzog et al., 1998) , spleen, thymus (Komarova et al., 1997) and the small intestine (Merritt et al., 1994 (Merritt et al., , 1997 Komarova et al., 1997) . Our recent study showed that WT P53 is elevated to some extent in thymus, spleen, duodenum, jejunum, ileum, transverse colon and descending colon after gamma irradiation, which correlates with activated caspase-3, which is not seen in P53À/À tissues with or without gamma irradiation. All of the above clearly show that P53 plays a crucial role in IR responses. What are the mechanisms underlying all of the above? The phenomenon that cells lacking ATM showed a reduced and delayed activation of P53 in response to DNA damage (el Khodairy et al.,
1992) implied that P53 function in response to IR was ATM dependent; this is known as a fact (Canman et al., 1998; Turenne et al., 2001) . P53 is stabilized and activated in response to DSBs that are the primary DNA damage (Hutchinson, 1985; Ward, 1988) resulting from IR. However, the cascade of events signaling from DNA lesions to P53 stabilization and activation is very complex. P53 post-translational modifications and association with other proteins have been implicated in the regulation of its stability and transcriptional activities. P53's stability is regulated by binding with MDM2, and anything that interferes with the binding of MDM2 to P53 may increase P53 stability. The DNA damage of DSBs activates the checkpoint pathways, in which the DNA damage is recognized by sensors that transduce ( Figure 1 ) the damage signal to the elements composed of transducers to modify P53 post-translationally and protect P53 from degradation mediated by MDM2. Specifically, activated ATM, which results from the DNA DSBs, phosphorylates CHK1 and CHK2, which in turn phosphorylate P53 at Ser20 Shieh et al., 2000) . In the meantime, P53 and MDM2 are phosphorylated by ATM directly at Ser15 (Canman et al., 1998) and Ser395 (Maya et al., 2001) , respectively. Both phosphorylated Ser15 and Ser20 on P53 and phosphorylated MDM2 are located in the region where P53 and MDM2 interact with each other. These phosphorylations thus interrupt the binding of MDM2 with P53 and protect P53 from ubiquitination and degradation. Recently, hypophosphorylated MDM2 in response to IR was also found to contribute to P53 stabilization, which is distinct from MDM2's ubiquitin ligase activity to mediate P53 degradation (Blattner et al., 2002) . Other post-translational modifications on P53 can modify its stability under certain circumstances. In terms of P53's transcriptional activity and its regulation, P300 and PCAF histone acetyltransferases are known to be involved in promoting transactivation of P53 target genes (Liu et al., 1999; Shikama et al., 1999) by acetylating Lys382 and Lys320, respectively, on P53 Liu et al., 1999) . On the other hand, HDAC and Sir2adea-cetylases were shown to inactivate P53 function (Luo et al., 2000 (Luo et al., , 2001 Chiou et al., 2001; Vaziri et al., 2001) . Recently, a couple of groups performed excellent studies and revealed novel mechanisms in the regulation of P53 function, including how Pin 1's interaction with Ser 33, Thr81 and Ser315 phosphorylated P53, generating conformational changes in P53 and enhancing P53 transactivation activity (Zacchi et al., 2002) . Also, Parc was identified as a cytoplasmic anchor to regulate P53 activity (Nikolaev et al., 2003) , although the phenomenon of cytoplasmic protein responsible for holding P53 in the cytoplasm to regulate P53 function was noticed more than a decade ago (Gannon and Lane, 1991) . In comparison with proteins promoting P53 stability, it is much less clear how these proteins promoting P53 transactivation activity are regulated in response to IR. So, studies focusing on these proteins in IR responses or any DNA damage response may enhance our under-standing of the P53 transactivation of its target genes, specifically in redundancy or/and selectivity among a large number of targets.
Role of WT P53 in cell cycle arrest in response to IR Checkpoints work on cell cycles in response to DNA damage by directly or indirectly influencing the timing of CDK activation (Elledge, 1996) . Thus, CDKs are not only the key regulators of cell cycle transitions but are also the effectors of checkpoints. Although cell cycle transitions depend on the underlying CDK cycle, superimposed checkpoint controls help ensure that certain processes are completed before others begin. A critical conceptual distinction between cell cycle phase transitions and operation of these checkpoints is that components of checkpoint control do not need to be essential to the workings of the cycle. Instead, their role is to control the cycle in the face of stress or damage (Hartwell and Weinert, 1989) . There have been significant improvements in our understanding of the mechanisms governing DNA damage-induced cell cycle arrest over the past decade. Much of this has come about by the convergence of information from diverse model systems including yeast, frog, mouse and human cells. In mammalian cells, following IR, it was observed years ago that cells were halted in G1 and/or G2 phases and delayed in the S phase (Little, 1968; Kastan et al., 1991a, b) .
G1 arrest enforced by G1 DNA damage checkpoint
A body of evidence indicates that P53 is required for proper G1 DNA damage checkpoint function (Kastan et al., 1991a, b; Kuerbitz et al., 1992; Donehower and Bradley, 1993) (Selivanova and Wiman, 1995; Ko and Prives, 1996; Prives and Hall, 1999) . Both P53 stability and specific activity as a transcription factor appear to be increased Pietenpol et al., 1994) , which is now clear and results from posttranslational modifications on P53 that occur upon DNA damage, interrupt the interaction of MDM2 and P53, and prevent P53 from ubiquitin-mediated proteolysis. The G1 arrest triggered by the IR occurs largely through the transactivation of P21 Waf1 (El-Deiry et al., 1993) by WT P53, which inhibits G1 cyclin-dependent kinases, maintains the Rb-E2F complex, and consequently prevents S phase entry (Gottlieb and Oren, 1996; Ko and Prives, 1996) , thus halting the damaged cells from ondergoing DNA replication. P21
Waf1 (ElDeiry et al., 1993) has been identified as the means by which WT P53 induces G1 arrest, because it contains WT P53-binding elements in its promoter. This same gene was isolated independently by Harper et al. (1993) as a CDK2-interacting protein (CIP1). In later studies, the CIP1 gene was found to encode a potent inhibitor of CDK activity, and CIP1
Waf1 turned out to be the P21 protein originally observed in CDK immune complexes from untransformed cells (Xiong et al., 1992) . P21 was also discovered to be a factor that was markedly upregulated in senescent cells (Noda et al., 1994) ; it is a potent inhibitor of the CDKs (cyclin A/CDK2, cyclinE/CDK2 and cyclinD1/CDK4) and provides a mechanism by which WT P53 can inhibit the cell cycle engine in the G1 phase (Dulic et al., 1994; El-Deiry et al., 1994) . In addition to the phenomenon that G1 arrest mediated by P53 activation after IR facilitates DNA repair, the phenomenon of senescence-like growth arrest (SLGA) after IR was recently discussed (Watanabe et al., 2002) . Furthermore, a P53-independent G1 DNA damage checkpoint may involve c-ABL kinase. ATM, when activated, phosphorylates and activates c-ABL kinase, which in turn can activate P73 and potentially result in the transactivation of P21 and GADD45 . ATM and c-ABL may mediate a checkpoint function through P73. Thus, ATM may mediate the G1/S checkpoint through a direct phosphorylation of P53 or through phosphorylation of c-ABL, which, in turn, can upregulate P21 through P73 activation (Dasika et al., 1999) . Other CDK inhibitors, P27KIP1 and P15INK4B, were noted to be activated by irradiation and may contribute to the G1 arrest in a P53-independent manner (Teyssier et al., 1999) as well.
P53 and S phase delay in IR response
It was observed almost 20 years ago (Painter, 1985) that irradiation of cells results in delayed progression during the S phase of the cell cycle. The lack of functional ATM renders this delay defective, causing radioresistant DNA synthesis (RDS); Nijmegen breakage syndrome (NBS) cells and ataxia-telangiectasia (AT) cells (Painter and Young, 1980) were first noted to possess this defect. Although most of the proteins involved are conserved through evolution, a molecular understanding of this delay came out only recently, which is referred to as the S phase DNA damage checkpoint (SDDC) (Larner et al., 1997; Zhou and Elledge, 2000) . Many recent studies in mammalian systems showed that ATM, NBS1, CHK2, CDC25A, BRCA1, SMC1, MRE11 and others are required for S phase delay in response to IR (Lim et al., 2000; Falck et al., 2001 Falck et al., , 2002 Kastan et al., 2001; Kim et al., 2002; Williams et al., 2002) . These proteins generally form two signal transduction pathways. One is the ATM/CHK2/CDC25A pathway, within which activated ATM activates CHK2, and CHK2 phosphorylates the cell cycle regulator CDC25A, leading to its degradation by the polyubiquitinationmediated proteolysis, and thus maintaining the inhibitory phosphorylation on CDK2 (unable to initiate DNA replication). The other is the ATM/ NBS1/BRCA1/SMC1 pathway, which places NBS1, BRCA1 and SMC in a complex where all are phosphorylated by ATM and directly or indirectly affect CDK2 activity. Both pathways do not exclude each other, that is, NBS1 may facilitate the phosphorylation of CDC25A and lead to its degradation (Falck et al., 2002) . The relation among proteins functioning in S phase arrest is very subtle and specific, although it remains largely unknown. A recent study (Xu et al., 2002b) indicated that a specific S 1387 phosphorylation on BRCA1 by ATM is essential for IR-induced S phase arrest. Unlike the roles of P53 in both G1/S and G2/M arrests, mediated through its targets, the role of P53 in SDDC triggered by IR seems much more elusive. So far, P53 has been reported to be involved in S phase delay only at lower levels, probably due to depletion of the substrates required for DNA synthesis (Agarwal et al., 1998; Taylor and Stark, 2001) and the relatively high level of P53 protein that presumably contributes to G1 and G2 arrests. The details regarding P53's role in S phase delay/arrest in response to IR are awaiting future study.
P53 and G2/M arrest following IR
The exact upstream events leading to G2/M arrest are not known with certainty, although a number of genes have been implicated in the response. In budding yeast, for example, G2 delay is primarily dependent on RAD9. In mammalian cells, the product of the AT gene seems to contribute to the arrest (Elledge, 1996; Paulovich et al., 1997) . A number of genes such as HCHK1 and HCHK2 (Sanchez et al., 1997; Matsuoka et al., 1998) , reported as having roles in a G2 DNA damage checkpoint, suggest the involvement of these gene products in the signal transduction pathway that regulates CDK1 activity upstream. Evidence obtained using Schizosaccharomyces pombe, Xenopus egg extracts and human cells has provided the basis for an extended model of the G2 DNA damage checkpoint revolving around regulatory phosphorylation events (Furnari et al., 1997; Peng et al., 1997; Sanchez et al., 1997) . In this model, DNA damage triggers activation of kinases of the RAD3/MEC1/TEL1/ATM family, which either directly or indirectly activates the downstream kinase CHK1. In turn, CHK1 phosphorylates CDC25C in mammalian cells, promoting its sequestration by 14-3-3 protein(s). As long as the pathway is activated, CDC25C remains inaccessible, CDC2-cyclin B heterodimers remain inactive, and the cell remains in G2. It has been reported that there are two distinct G2/M checkpoint pathways: one is ATM dependent, IR-dose independent and of rapid response, as stated above (Xu et al., 2002a) ; the other is a prolonged response, ATM independent and IR-dose sensitive; this prolonged G2/M delay is partly due to the loss of IR-induced S phase checkpoint response (Xu et al., 2002a) . Originally, G2/M arrest was found in P53-null or P53-mutated cells, which suggested that P53 was not required in G2/M arrest (Passalaris et al., 1999) . Studies have reported that overexpression of P53 (Azzam et al., 1997; Innocente et al., 1999) or its downstream effector proteins, such as 14-3-3s and GADD45, can induce G2/M arrest (Hermeking et al., 1997; Wang et al., 1999 ). 14-3-3s can sequester the proteins of cyclin B1 and CDC2 that initiate mitosis and prevent them from entering the nucleus (Chan et al., 1999) , and GADD45 can destabilize CDC2/cyclin B complexes Jin et al., 2002) . P53 also suppresses promoters of CDC2 and cyclin B and leads to G2/M arrest (Passalaris et al., 1999) . A role for P53 in G2/M arrest as a contributing factor is plausible. P53 now is known to be involved in the secondary regulation of G2/M arrest to sustain the G2/M arrest (Passalaris et al., 1999) . However, the mechanism(s) appear much more complicated and have not been clearly determined in comparison with G1 arrest. The role of P53 in G2/M seems very redundant; the decreased CDC2/cyclin B kinase activity is either through P53 transcriptional repression of CDC2 and cyclin B or P53 targets that interfere with the CDC2/ cyclin B complex. Interestingly, the two pathways in G2/ M arrest in response to IR are not clearly linked to radiosensitivity (Xu et al., 2002a) . However, how P53 is coupled into these two pathways has not been thoroughly studied; it could be the third pathway or a supplement to ATM-dependent or/and ATM-independent prolonged G2/M arrest. Further studies to clear these questions may improve our knowledge regarding the mechanisms of G2/M arrest and P53's roles in radiosensitivity.
P53 and DNA DSB repair
The DSB of DNA, as a signal of IR damage, activates the DNA damage checkpoint and leads to binding of sensor proteins to DNA followed by the massive phosporylation events, ultimately resulting in cell growth arrest coupled with DNA damage repair or apoptosis to eliminate cells with irreparable DNA damage. There are two distinct and complementary mechanisms for DNA DSB repair; homologous recombination (HR) and nonhomologous end-joining (NHEJ) (Karran, 2000; Khanna and Jackson, 2001 ). The known crossover or holiday junction mechanism in HR is now recognized to be involved mainly in meiotic events. A variant of HR, the single-strand annealing pathway, takes place in mitotic DSB homologous recombination repair (Johnson and Jasin, 2000) . Whereas the NHEJ of two DNA ends does not require extensive homologies between two recombining ends, there is a limited degradation at the termini during ligation of the two ends. The components composed of DNA DSB repair in NHEJ are DNA-PK, Ku70, Ku80, ligase IV, XRCC4 and others; in HR, they are ATM, BLM, BRA1/2, c-ABL, RAB51/51C/51D/52/54, XRCC2/3 and others. In addition, the complex of RAD50, MER11 and NBS1 is involved in both HR and NHEJ (Khanna and Jackson, 2001) . Unlike the roles of P53 in cell growth arrest, which are mediated largely through its wellknown targets to inhibit CDKs and lead to cell cycle arrest, the role of P53 in DSB repair may be mediated largely through itself although its target-P53R2 has a role in DNA repair (Tanaka et al., 2000) . P53 has been shown to bind nonspecifically to single-stranded and double-stranded DNA detect regions of damaged DNA and promote annealing of single-stranded nucleic acids P53 and radiation responses P Fei and WS El-Deiry (Ko and Prives, 1996; Levine, 1997 ). P53 appears to be linked to both principal repair pathways, nonhomologous and homologous recombination, such as interaction with RAD 51 and BRCA1 (Sturzbecher et al., 1996; Jongmans et al., 1998) , and both NBS and DNA-PK are able to modulate P53 function (Jongmans et al., 1997; Kachnic et al., 1999) . The P53 COOH-terminal has been reported to have exonuclease activity and be involved in rejoining DSBs following gamma irradiation in mouse embryonic fibroblasts (MEFs) and in human lymphoblastic cell lines (Mallya and Sikpi, 1998) . P53 may be able to restrain DNA exchange between imperfectly homologous sequences (Akyuz et al., 2002) . In addition, one well-characterized response to DNA damage is for cells to slow down progression through the cell cycle, which is mainly mediated through P53, to provide time for repairing damage and therefore prevent DNA damage from being propagated, which implicates P53 as essential in damage repair. BRCAl was recently found to stabilize P53 and direct cells more toward growth arrest and DNA repair, which is mediated not only through cell cycle arrest targets like P21 but also DNA repair genes such as XPE DDB2 and others. However, an increase in the length of time for repair might carry risks and increase the possibility of generating variants with chromosome aberrations (CAs) derived from misrepair of 'complex lesions' that frequently occur following IR (Di Leonardo et al., 1994; Wahl and Carr, 2001; Jeggo, 2002) . In response to lower levels of DNA damage, checkpoints trigger P53 accumulation to mediate a reversible arrest, which would give a right timing for the lower level of damage repair, and to fulfill P53 function to ensure genetic stability. The checkpoints enforce a given cell's death by inducing apoptosis, which is accepted as the default pathway when the damage is obviously irreparable. In response to large amounts of DNA damage, the level of P53 presumably is boosted and a longer time arrest may arise; apoptotic response may be initiated. However, the CAs may be generated when irreparably DNA-damaged cells cannot be removed right away, which would happen when there is a defect(s) in an apoptotic pathway.
P53-mediated apoptosis in IR
A large amount of evidence indicates that unrepaired or misrepaired DSBs in the DNA can lead to cell death/ apoptosis (Ward, 1988; Frankenberg-Schwager, 1989; Iliakis, 1991; McMillan and Peacock, 1994; Jeggo, 1998) . The death resulting from radiation is now, to a considerable degree, understood as radiosensitivity. Although some cell lines with WT P53 show radiosensitivity (Servomaa et al., 1996) , much evidence has indicated that WT P53 plays a crucial role in mediating radiosensitivity. In vitro cell line studies have showed that P53 mutations are associated with increased radioresistance (Bristow et al., 1994; McIlwrath et al., 1994; Yount et al., 1996) . In vivo WT P53 has proven to be essential in determining the radiosensitivity in a variety of tissues (Lowe et al., 1993; Merritt et al., 1994; MacCallum et al., 1996; Komarova et al., 1997; Merritt et al., 1997; Herzog et al., 1998; Bouvard et al., 2000; Burns et al., 2001) . Our recent study showed correlation between irradiation-induced apoptotic activity and WT P53 status in various tissues. Accumulated and activated P53 leads to cell cycle arrest that may facilitate DNA repair and/or leads to apoptosis. The mechanism by which P53 mediates apoptosis can generally be classified into two categories: transcription independent and transcription dependent. The evidence of transcription-independent P53-mediated apoptosis, although not abundant, is accumulating (Caelles et al., 1994; Wagner et al., 1994; Gao and Tsuchida, 1999) . Mihara et al. (2003) recently reported that P53 can interact with BCL-XL and BCL-2 to exert its direct apoptogenic function at mitochondria. So far, a large number of P53 target genes with proapoptotic activity have been identified. They fall into three groups based on their subcellular location (Benchimol, 2001 ). The first group of genes encodes proteins that localize to the cell membrane (e.g., CD95, KILLER/DR5, PERP) (Owen-Schaub et al., 1995; Muller et al., 1998; Wu et al., 1997 Wu et al., , 1999 Attardi et al., 2000) . The second group of genes encodes proteins that localize to the cytoplasm, including PIDD and PIGs Lin et al., 2000) . The third group of genes encodes proteins that localize to the mitochondria (e.g., BAX, NOXA, PUMA, P53
Aip1
, BID) (Miyashita et al., 1995; Oda et al., 2000a, b; Sax et al., 2002) . Among all of the above genes, the disappointment is that none of them appears to be a principal mediator of the P53 apoptotic signal. There may be uniqueness among P53 targets, and there may be tissue/cell-type specificity in their regulation in response to IR or other DNA damage agents. In addition, there may be coordinate regulation of apoptotic targets that may ultimately correlate with radiosensitivity. Our recent systematic study from P53 þ / þ or P53À/À mice with or without gamma irradiation showed the apparent tissue specificity with which P53 selects targets for activation. For example, PUMAwas greatly induced in P53 þ / þ spleen white pulp, NOXA in P53 þ / þ thymus and BID in P53 þ / þ transverse colon. Future studies will determine the mechanisms by which WT P53 transactivates different target gene(s) in different tissues, with the possible involvement of tissue-specific factor(s), and the degree of each given tissue to accept damage insults or/and others. The net outcome derived from all combinations may direct P53 to transactivate selectively its apoptotic targets to initiate P53-dependent apoptosis.
Choice to die or to live
The eucaryotic strategy to deal with damaged DNA can be split into three components: the recognition of injured DNA, a period of damage assessment, and the implementation of the appropriate response, DNA repair or cell death (Elledge, 1996; Zhou and Elledge, 2000) . These procedures are not activated in a simple linear fashion because the damage recognition elicits multiple signal tranduction cascades that can trigger both repair and apoptotic processes. P53 provides one well-studied example of how the decision between apoptosis and other fates can be made at checkpoints activated by DNA damage (Sionov and Haupt, 1999) . For most replicative cell populations, P53 levels increase within minutes of DNA damage, and the first apoptotic events occur within a few hours (Clarke et al., 1994; Merritt et al., 1994) . How does the activation of P53 by DNA damage lead to initiation of apoptosis or cell arrest? This may be explained by P53 selectively transactivating its target genes, such as P21, GADD45, members of the 14-3-3 family and others that are cell cycle regulators, as well as BAX, CD95, DR5 and others that are members of the core apoptotic pathways. Selectivity of P53 transactivation may result from its specific post-translational modification or its interacting proteins. For example, the phosphorylation of Ser46 on P53 regulates the transcriptional activation of P53AIP1 apoptosis-inducing gene (Oda et al., 2000b) . Based on P53 targets identified from other labs and ours, we summarized the roles of P53 in radiation responses (Figure 2 ) in determining the cell's fate to live by inducing cell arrest, coupled with DNA repair, or to die by inducing apoptosis. In regard to this figure, it is worth mentioning here that the function of P53 target genes in apoptosis may be generalized into two aspects: directly mediating cell death to contribute to radiosensitivity (PUMA, P53AIP1, DR5 and others) and lowering the threshold of cell death to sensitize the chemo-or radiosensitivity (APAF1, caspase-6, BID and others) (Moroni et al., 2001; Sax et al., 2002) . Many studies have suggested that the intensity of the stress condition/DNA damage, the level of P53 expressed and its interacting proteins may arbitrate two choices of outcome, and that cell type, oncogenic composition and the extracellular stimulus may also influence the choice (Prives and Hall, 1999; Sionov and Haupt, 1999; Offer et al., 2002) . Specifically, for IR, the intensity of DNA damage appears to be an important determinant. The dosage of IR may predict the outcome of cell fate: lower doses of IR initiate reversible cell growth arrest (Kastan et al., 1991a) and higher doses of IR trigger apoptosis. There are possibly a number of choices that have been made by upstream components before the signaling is even passed to P53 within the radiation response. For example, phosphorylation of Ser345 on CHK1 has been found to be associated with P53-dependent cell cycle arrest pathways after radiation (Tian et al., 2002) . Ser1423 phosphorylation on BRCA1 is essential in ATMdependent G2/M arrest after IR (Xu et al., 2002b) . Both imply that whether cells undergo arrest or apoptosis may be determined early when the damage is introduced, with P53 possibly integrating a plethora of signals. Other factors may play a role in modifying the choice of outcome. However, the intensity of DNA damage holds a dominant role in directing the cascade of changes imposed by checkpoint-surveillance mechanisms.
Conclusion
Multicellular organisms elicit a complex response to IR, which is hard to separate from the fact that they have evolved to have P53 in checkpoint pathways. The checkpoint thus is not equated with 'arrest for repair' that was derived from the extensive studies in yeast. Instead, an additional cell fate of apoptosis is included in the possible outcomes of cell fate in higher eucaryotic systems in response to a variety of stress conditions. P53 plays an important role in the response of IR. P53 is stabilized in vitro and in vivo after IR. The level of P53 protein accumulation in response to IR primarily results from the intensity of DNA damage. Posttranslational modifications of P53 and its interacting proteins determine its stability and transactivation activity. This stabilization and activation is important for P53's roles in inducing growth arrest when reversible, which is coupled with DNA damage repair to protect cells from the IR damage. Apoptosis occurs in response to a high dose of IR when the damage is irreparable, in order to eliminate the damaged cells. The mechanism by which P53 mediates cell arrest and apoptosis is largely mediated through its target genes, although some transcriptional-independent phenomena have been reported in other systems. The dosage of IR 
P53 itself
Figure 2 Schematic presentation of roles of P53 in radiation responses. P53-dependent effects in response to IR/DNA damage are mediated through either p53 itself or transactivating its target genes. The target gene expressions may result in reversible arrest coupled DNA repair, which leads to the fate of cell survival, cell death or result in synergy apoptosis, which attributes to the fate of cell death P53 and radiation responses P Fei and WS El-Deiry predominantly contributes to the outcomes of cell fate, either survival or death. The role of P53 in DSB repair may involve P53 directly. The role(s) of P53 in the S phase arrest/delay are elusive. At the present time, we are gaining much insight regarding the roles of P53 in DSB repair. Further studies on P53 functioning at the switch from reversible arrest to triggering apoptosis may offer a greater understanding of radioresistance and radiosensitivity.
